Raze Therapeutics
25 First Street
Suite 303
Cambridge
Massachusetts
02141
United States
Tel: 617-588-2600
Website: http://www.razetx.com/
7 articles about Raze Therapeutics
-
Kindness. Respect. Innovation. Only one of those words typically features in biotech mission statements, but at Ikena Oncology, all three are important – and have been from day one.
-
As part of a portfolio update, Altas Ventures noted that Raze Therapeutics, a biotech launched in 2014, has closed its doors.
-
Raze Therapeutics Announces Addition Of Robert Copeland, Phd, To Scientific Advisory Board
5/28/2015
-
Raze Therapeutics Appoints Mark Manfredi As Chief Scientific Officer
4/7/2015
-
Raze Therapeutics Announces Addition Of Julian Adams, PhD, George Q. Daley, MD, PhD, And Karen Vousden, Phd, To Scientific Advisory Board
1/7/2015
-
Raze Therapeutics Appoints Mikel Moyer, PhD, As Vice President, Molecular Discovery
10/28/2014
-
Raze Therapeutics Snags $24M For Cancer Drugs
10/14/2014